BioSpace News Archive

Genetown

TScan Therapeutics Named Top Place to Work by The Boston Globe for Two Consecutive Years

TScan Therapeutics, Inc. announced it has been named one of the Top Places to Work in Massachusetts in the 16th annual employee-based survey project from The Boston Globe.

November 30, 2023
·
3 min read
Pharm Country

Trevena Announces Acceptance of Abstract Examining the Use of OLINVYK in Patients with Acute Burn Injuries

Trevena, Inc. announced the acceptance of an abstract based on the pRospective, case-controlled Evaluation of oLIceridine for moderate or sEVEre pain in patients with acute burn injuries study at the 2024 ABA annual meeting, being held April 9th-12th in Chicago.

November 30, 2023
·
12 min read
Pharm Country

Tiziana Life Sciences Announces Foralumab Dosing of Four New Patients in the Expanded Access Program for Multiple Sclerosis

Tiziana Life Sciences Ltd. announced that the company has successfully enrolled and dosed four new patients with non-active secondary progressive multiple sclerosis in the Brigham and Women’s Hospital, a founding member of Mass General Brigham Healthcare System Expanded Access Program.

November 30, 2023
·
3 min read
Drug Development

BriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic Tumor

BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company that develops novel immunotherapies to transform cancer care, is thrilled to announce a new remarkable responder in our Phase 2 study of the Bria-IMT™ combination regimen.

November 30, 2023
·
5 min read
BioCapital

Innovent’s MSCI ESG Rating Upgraded to A

Innovent Biologics, Inc. announces that the Company has been upgraded to ‘A’ according to Morgan Stanley Capital International’s latest ESG rating, ranking at the forefront of the biotechnology industry.

November 30, 2023
·
10 min read
Lone Star Bio

Nanoscope Therapeutics to Present at Ophthalmology Innovation Summit (OIS) XIII

Nanoscope Therapeutics Inc. today announced that Jared Stephens , PhD, Vice President of Strategy and Business Development, will present at the 13th Annual Ophthalmology Innovation Summit (OIS) taking place from December 1-2 in San Diego, California.

November 30, 2023
·
1 min read
Fresenius Medical Care completes change of legal form into a German stock corporation

Fresenius Medical Care announces the successful completion of its change of legal form from a partnership limited by shares into a German stock corporation as of November 30, 2023.

November 30, 2023
·
4 min read
Drug Development

SciNeuro completes dosing in its Phase 1 clinical trial of SNP318, an oral therapeutic for Alzheimer’s disease and other neurodegenerative diseases

SciNeuro Pharmaceuticals today announced the completion of dosing in its Phase 1, randomized, double-blind, placebo-controlled, single and multiple ascending dose study.

November 30, 2023
·
4 min read
Business

Peptone and The Institute of Oncology Research (IOR) Bellinzona Announce Collaborative Research Agreement

Peptone, a leader in translational biophysics and the design of novel therapeutics against intrinsically disordered proteins (IDPs), and The Institute of Oncology Research (IOR) today announced the commencement of a collaborative sponsored research agreement in prostate cancer.

November 30, 2023
·
2 min read
Genetown

SOPHiA GENETICS Announces Expansion of Work with CHU de Nîmes

SOPHiA GENETICS announced that it has expanded its work with CHU de Nîmes, a regional and university hospital located in the South of France.

November 30, 2023
·
4 min read